Eupraxia Pharmaceuticals Inc.

Eupraxia Pharmaceuticals is developing prescription drugs to treat diseases that currently have few or no good treatment options. The company uses a technology called Diffusphere that is designed to deliver drugs more effectively to the parts of the body where they are needed. Their main drug candidate is being tested in a late-stage clinical trial for knee osteoarthritis, while another is in earlier testing for eosinophilic esophagitis, a condition where the throat becomes inflamed.